• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ahead of Our Time: Collaboration in Modeling Then and Now.

作者信息

Arnold Renée J G, Ekins Sean

机构信息

Arnold Consultancy & Technology, LLC, New York, NY, 10023, USA.

Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, NC, 27606, USA.

出版信息

Pharmacoeconomics. 2017 Sep;35(9):975-976. doi: 10.1007/s40273-017-0532-2.

DOI:10.1007/s40273-017-0532-2
PMID:28660474
Abstract
摘要

相似文献

1
Ahead of Our Time: Collaboration in Modeling Then and Now.领先于时代：过去与现在的建模合作
Pharmacoeconomics. 2017 Sep;35(9):975-976. doi: 10.1007/s40273-017-0532-2.
2
Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling.分享即关怀：药物经济学建模中公司层面合作的案例
Pharmacoeconomics. 2017 Aug;35(8):755-757. doi: 10.1007/s40273-017-0516-2.
3
Modeling for health care and other policy decisions: uses, roles, and validity.
Value Health. 2002 Jan-Feb;5(1):62-3; author reply 61-2.
4
Predictive validity of pharmacoeconomic modeling.
Am J Health Syst Pharm. 2000 Jul 1;57(13):1274-6. doi: 10.1093/ajhp/57.13.1274.
5
Managed care executives see utility in economic modeling for specialty injectables.
Manag Care Interface. 2005;Suppl:12-3.
6
The special interdisciplinary contribution of institutional economics.
Health Econ Policy Law. 2013 Jul;8(3):387-96. doi: 10.1017/S1744133113000182. Epub 2013 Apr 12.
7
Incorporation of uncertainty in health economic modelling studies.
Pharmacoeconomics. 2005;23(8):851-3; author reply 853. doi: 10.2165/00019053-200523080-00009.
8
PHR framework moves ahead. Markle Foundation collaboration offers guidelines.
Mod Healthc. 2008 Jun 30;38(26):14.
9
Adapting pharmacoeconomic data and methods to extend the postpublication utility of analyses.
Clin Ther. 2009 Jan;31(1):192-3. doi: 10.1016/j.clinthera.2009.01.008.
10
[Pharmacoeconomic analysis of antihypertensive therapy: advantages of fixed combinations].抗高血压治疗的药物经济学分析：固定复方制剂的优势
Kardiologiia. 2008;48(1):43-50.

引用本文的文献

1
Development of a pharmacoeconomic registry: an example using hormonal contraceptives.药物经济学登记册的开发：以激素避孕药为例。
Health Econ Rev. 2021 Mar 20;11(1):10. doi: 10.1186/s13561-021-00309-z.
2
The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.健康经济决策模型中的透明度和验证挑战：来自胡德山的观点。
Pharmacoeconomics. 2019 Nov;37(11):1305-1312. doi: 10.1007/s40273-019-00825-1.
3
Transparency in Decision Modelling: What, Why, Who and How?透明度决策模型：是什么、为什么、谁和如何？

本文引用的文献

1
Data-Sharing Models.数据共享模型。
N Engl J Med. 2017 Jun 8;376(23):2305. doi: 10.1056/NEJMc1705477.
2
Data-Sharing Models.数据共享模型。
N Engl J Med. 2017 Jun 8;376(23):2305. doi: 10.1056/NEJMc1705477.
3
Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling.分享即关怀：药物经济学建模中公司层面合作的案例
Pharmacoeconomics. 2019 Nov;37(11):1355-1369. doi: 10.1007/s40273-019-00819-z.
Pharmacoeconomics. 2017 Aug;35(8):755-757. doi: 10.1007/s40273-017-0516-2.
4
Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview.卫生经济评估决策分析模型的验证：概述
Pharmacoeconomics. 2017 Jul;35(7):673-683. doi: 10.1007/s40273-017-0508-2.
5
Advantages of a Truly Open-Access Data-Sharing Model.真正开放获取的数据共享模式的优势。
N Engl J Med. 2017 Mar 23;376(12):1178-1181. doi: 10.1056/NEJMsb1702054.
6
Benefits, Challenges and Potential Strategies of Open Source Health Economic Models.开源卫生经济模型的益处、挑战及潜在策略
Pharmacoeconomics. 2017 Jan;35(1):125-128. doi: 10.1007/s40273-016-0479-8.
7
The Next Era: Deep Learning in Pharmaceutical Research.下一个时代：药物研究中的深度学习。
Pharm Res. 2016 Nov;33(11):2594-603. doi: 10.1007/s11095-016-2029-7. Epub 2016 Sep 6.
8
Model Validation: Has it's Time Come?模型验证：时机已到？
Pharmacoeconomics. 2016 Sep;34(9):829-31. doi: 10.1007/s40273-016-0415-y.
9
Time for cooperation in health economics among the modelling community.建模界开展卫生经济学合作的时机已到。
Pharmacoeconomics. 2010;28(8):609-13. doi: 10.2165/11537580-000000000-00000.